Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer - Concepedia

Concepedia

Publication | Open Access

Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer

DOI Full Paper Access

102

Citations

12

References

2018

Year

Makoto Tahara, Marcia S. Brose, Lori J. Wirth, Takuya Suzuki, Hideaki Miyagishi, Katsuki Fujino, Corina E. Dutcus, Andrew G. Gianoukakis

European Journal of Cancer

Abstract

NCT01321554.

References

	Year	Citations

Page 1